Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients

NCT05167513 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Quality of Life
Type 2 Diabetes
Metformin+Sitagliptin

Interventions

DRUG: Metformin / Sitagliptin Oral Tablet

Sponsor

Getz Pharma